corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 70 of 144 pages ‹ First  < 68 69 70 71 72 >  Last ›

HSL8292
Lilly CEO Made $15.2 Million Last Year
Associated Press 2007 Feb 6
http://www.abcmoney.co.uk/news/04200782226.htm

HSL8293
Sutel S.
NYT Staffer Won't Appear in Zyprexa Case
Associated Press 2007 Feb 6
http://www.firstamendmentcenter.org/n-y-times-journalist-wont-testify-in-pharmaceutical-case

HSL8294
Johnson CK.
Safety of Heart-Surgery Drug Questioned
Associated Press 2007 Feb 6
http://www.anapolschwartz.com/practices/trasylol/blog/bleeding-aprotinin.html

HSL8298
Healy D.
Why you should never trust new wonder drugs
The Daily Mail 2007 Feb 6
http://www.dailymail.co.uk/pages/live/articles/health/healthmain.html?in_article_id=434241&in_page_id=1774

HSL8320
Smith M.
Teen Suicide Spike Linked to SSRI Black Box
MedPage Today 2007 Feb 6
http://www.medpagetoday.com/Pediatrics/GeneralPediatrics/tb2/5005#ayk

HSL8477
Abel D.
Hull parents arrested in girl's poisoning death
The Boston Globe 2007 Feb 6
http://www.boston.com/news/local/articles/2007/02/06/hull_parents_arrested_in_girls_poisoning_death/

HSL8500
Ruff ME.
ADD and Stimulant Use: An Epidemic of Modernity
Medscape Pediatrics 2007 Feb 6
http://www.medscape.com/viewarticle/550918_1

HSL8058
The Doctor Won't See You Now
Business WeeK Online 2007 Feb 5
http://www.businessweek.com/magazine/content/07_06/b4020046.htm?campaign_id=rss_topStories

HSL8252
Ulene V.
Medical merchants
Los Angeles Times 2007 Feb 5
http://docadvocate.com/?p=758

HSL8254
Drugmaker Roche Boosting Spending on Research and Development, Forming 2 New U.S. Units
Associated Press 2007 Feb 5
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=16774132

HSL8255
Lewcock A.
AstraZeneca's job cuts latest symptom of widespread trend
InPharmaTechnologist 2007 Feb 5
http://www.in-pharmatechnologist.com/news/ng.asp?n=73924-astrazeneca-pfizer-job-cuts-restructuring-industry

HSL8273
Shern D.
Increased Suicide Rate in Children and Teens Found
Mental Health America 2007 Feb 5
http://www.nmha.org/index.cfm?objectid=9327EFEC-1372-4D20-C8CEAD8075905557

HSL8274
Pharma companies break Sweden's ad rules
The Local: News from Sweden in English 2007 Feb 5
http://www.thelocal.se/6302/20070205/

HSL8276
Pringle E.
Nobody Buys Lilly's Innocence Routine About Zyprexa
OpEd News 2007 Feb 5
http://www.opednews.com/articles/genera_evelyn_p_070205_nobody_buys_lilly_s_.htm

HSL8281
Ginsberg T.
Threat to health-data cottage industry
The Philadelphia Inquirer 2007 Feb 5
http://health.groups.yahoo.com/group/iatrogenic/message/2926

HSL8411
Hong E.
WHO DG's Shocking Views on Compulsory Licensing Criticised by Health Movements and Experts
Third World Network 2007 Feb 5
http://www.twnside.org.sg/title2/health.info/twninfohealth072.htm

HSL8253
Wachman R.
Big Pharma set to dissolve as competition dilutes profit
The Observer 2007 Feb 4
http://observer.guardian.co.uk/business/story/0,,2005202,00.html

HSL8257
Nass M.
Facts Behind Merck's Mandatory Vaccine Campaign to Help Pay for Vioxx
Alliance for Human Research Protection 2007 Feb 4
http://www.ahrp.org/cms/content/view/457/31/

HSL8289
Engel M.
Young doctors see drug makers' freebies as a bad habit
Los Angeles Times 2007 Feb 4
http://www.commercialalert.org/news/archive/2007/02/young-doctors-see-drug-makers-freebies-as-a-bad-habit

HSL8152
Hargreaves S.
Ghost authorship of industry funded drug trials is common, say researchers
BMJ 2007 Feb 3; 334:(7587):223
http://www.bmj.com/cgi/content/full/334/7587/223

HSL8155
Lenzer J.
Telling the inside story?
BMJ 2007 Feb 3; 334:(7587):261
http://www.bmj.com/cgi/content/full/334/7587/261

HSL8157
Iheanacho I.
Drug tales and other stories: On the cheap
BMJ 2007 Feb 3; 334:(7587):262
http://www.bmj.com/cgi/content/full/334/7587/262-a

HSL8258
Pringle E.
Zyprexa: the Injury Clock Keeps Ticking Away
Counterpunch 2007 Feb 3-4
http://www.counterpunch.org/pringle02032007.html

HSL8279
Texas governor orders STD vaccine for all girls
Associated Press 2007 Feb 3
http://www.newscloud.com/read/79615/?showComments

HSL8667
Zwillich T.
US FDA seeks more pharmaceutical industry cash.
Lancet 2007 Feb 3; 369:(9559):357
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17283497&query_hl=8&itool=pubmed_DocSum

HSL8668
[No authors listed] .
Resisting prescribing pressure for sildenafil.
Lancet. 2007 Feb 3; 369:(9559):344
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(07)60162-7

HSL8669
Hargreaves S.
More than 200,000 people ask Novartis to drop its challenge on drug patent.
BMJ 2007 Feb 3; 334:(7587):226
http://www.bmj.com/cgi/content/full/334/7587/226-a

HSL8106
Herper M.
Why Bristol And Sanofi Shouldn't Merge
Forbes.com 2007 Feb 2
http://www.forbes.com/2007/02/01/bristol-sanofi-merger-biz-cz_mh_0202bristol.html?partner=yahootix

HSL8145
Zehr L.
Drug giants have Bristol in their cross-hairs
The Globe and Mail (Toronto) 2007 Feb 2
http://www.theglobeandmail.com/servlet/story/LAC.20070202.REDGE02/TPStory/Business

HSL8147
Mathews AW.
Drug Industry Faces Bitter Pill
Wall Street Journal 2007 Feb 2A6
http://users1.wsj.com/lmda/do/checkLogin?mg=wsj-users1&url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FSB117038278628795740.html%3Fmod%3Dwsj_right_click

HSL8259
Cancer vaccine's price, insurance problems limiting patient access
Associated Press 2007 Feb 2
http://money.aol.com/news/articles/_a/cancer-vaccines-price-insurance-problems/n20070202173409990016?cid=1219

HSL8295
Abramson J, Norsigian J.
Cold-hearted Tug Fails Women
Atlanta Journal-Constitution 2007 Feb 2

HSL8317
Studies overdue for drugs in use
Bloomberg News 2007 Feb 2
http://www.bloomberg.com/apps/news?pid=washingtonstory&sid=aNU3jba1kYIo

HSL8318
Kaiser Network.
Prescription Drug Makers Have Not Begun Many Pending Post-Market Studies on Newly Approved Drugs, FDA Says
Daily Health Policy Report 2007 Feb 2
http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=42696

HSL8083
Pringle E.
Judge in Zyprexa secret document case invites New York Times reporter to hearing
Online Journal 2007 Feb 1
http://web.archive.org/web/20080218100547/http://onlinejournal.com/artman/publish/article_1702.shtml

HSL8109
Norton K.
AstraZeneca Seeks a Stronger Pipeline
Business Week 2007 Feb 1
http://yahoo.businessweek.com/globalbiz/content/feb2007/gb20070201_178555.htm

HSL8146
Dixon K.
Botox's new ads to take on product's stereotypes
Reuters 2007 Feb 1
http://yahoo.reuters.com/news/articlehybrid.aspx?type=comktNews&storyID=urn:newsml:reuters.com:20070202:MTFH81299_2007-02-02_13-00-11_N01296468&pageNumber=1&imageid=&cap=&sz=13&WTModLoc=HybArt-C1-ArticlePage1

HSL8201
Lavelle E.
AstraZeneca to Cut 3,000 Jobs on Generic Competition
Bloomberg.com 2007 Feb 1
http://www.bloomberg.com/apps/news?pid=20601202&sid=aUO3334f5JcU&refer=healthcare

HSL8207
Philanthropy News Digest
Looking to Speed Drug Development, More Nonprofits Are Backing Drug Trials
Foundation Center 2007 Feb 1
http://foundationcenter.org/pnd/news/story.jhtml?id=168200003

HSL8296
King MA, Roberts MS.
The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes.
Pharm World Sci 2007 Feb 1;
http://www.springerlink.com/content/792177635401027v/

HSL8416
Berlin J, Bruinooge SS, Tannock IF.
Ethics in oncology: consulting for the investment industry.
J Clin Oncol 2007 Feb 1; 25:(4):444-6
http://www.jco.org/cgi/content/full/25/4/444

HSL8730
[No authors listed].
A changing drug supply.
Nature 2007 Feb 1; 445:(7127):460
http://www.nature.com/doifinder/10.1038/445460a

HSL9016
Young D.
Drug innovation on the decline.
Am J Health Syst Pharm 2007 Feb 1; 64:(3):228,
http://www.ajhp.org/cgi/content/full/64/3/228

HSL7583
Consumers Union of U.S.
Get better care from your doctor
ConsumerReports.org 2007 Feb
http://www.consumerreports.org/cro/health-fitness/health-care/choosing-the-right-doctor-2-07-getting-better-care/overview/0207_docs_ov.htm

HSL8203
Schafer A.
Science Scandal or Ethics Scandal? Olivieri Redux
Bioethics 2007 Feb; 21:(2):111-115
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1467-8519.2007.00531.x

HSL8211
Ducher M, Leutenegger E, Fauvel JP.
[Setting blood pressure targets in patients with uncontrolled hypertension: Physicians' subjective criteria.]
Presse Med 2007 Feb; 36:(2):192-196
http://www.masson.fr/masson/S0755-4982(06)00050-9

HSL8275
Cassels A.
Chronic disease management: Drug shareholders’ goldmine
Common Ground 2007 Feb
http://commonground.ca/iss/0702187/cg187_chronic.shtml

HSL8297
Wheeler DW, Wheeler SJ, Ringrose TR.
Factors influencing doctors' ability to calculate drug doses correctly.
Int J Clin Pract 2007 Feb; 61:(2):189-94
http://www.blackwell-synergy.com/doi/full/10.1111/j.1742-1241.2006.01273.x

HSL8418
Rapaport MJ, Franzblau M.
Drug companies, dermatologists, and the patient.
J Am Acad Dermatol 2007 Feb; 56:(2):333-4
http://linkinghub.elsevier.com/retrieve/pii/S0190-9622(06)02270-5

HSL8508
Twardella D, Brenner H.
Effects of practitioner education, practitioner payment and reimbursement of patients' drug costs on smoking cessation in primary care: a cluster randomised trial.
Tob Control 2007 Feb; 16:(1):15-21
http://tobaccocontrol.bmj.com/content/16/1/15.abstract

HSL8511
Duan JZ.
Applications of population pharmacokinetics in current drug labelling.
J Clin Pharm Ther 2007 Feb; 32:(1):57-79
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17286790&query_hl=7&itool=pubmed_docsum

HSL8512
Damanhori AH, Al Khaja KA, Sequeira RP, Al-Ansari TM.
Diurnal variation of prescribing pattern of primary care doctors in Bahrain.
J Eval Clin Pract 2007 Feb; 13:(1):25-30
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17286720&query_hl=10&itool=pubmed_DocSum

HSL8619
Ramlogan R, Mina A, Tampubolon G, Metcalfe JS.
Networks of knowledge: The distributed nature of medical innovation
Scientometrics 2007 Feb; 70:(2):459-489
http://www.springerlink.com/content/9976173u0342033g/

HSL8779
Fava GA.
Financial conflicts of interest in psychiatry.
World Psychiatry 2007 Feb; 6:(1):19-24
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1805729

HSL8941
Chimonas S, Brennan TA, Rothman DJ.
Physicians and drug representatives: exploring the dynamics of the relationship.
J Gen Intern Med 2007 Feb; 22:(2):184-90
http://www.springerlink.com/content/63878757451526p0/fulltext.html

HSL8960
Woloshin S, Schwartz LM, Kerin K, Welch HG.
Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States.
J Gen Intern Med 2007 Feb; 22:(2):197-204
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17356986

HSL9003
Feldman G.
Direct-to-consumer marketing.
Orthopedics 2007 Feb; 30:(2):89
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17323626&query_hl=5&itool=pubmed_DocSum

HSL9008
Namazu K.
[Operational aspect of participation in the multi-national clinical trials from the foreign pharmaceutical company's standpoint].
Gan To Kagaku Ryoho 2007 Feb; 34:(2):328-30
http://www.pier-online.jp/0385-0684/contents_abstract.php?serial_no=34020&seq=48

HSL9010
Nakagawa K.
[International clinical trials for a medical oncologist in Japan].
Gan To Kagaku Ryoho 2007 Feb; 34:(2):320-3
http://www.pier-online.jp/0385-0684/contents_abstract.php?serial_no=34020&seq=46

HSL9011
Miki S.
[Why multi-national clinical trials now?--Industry perspective]
Gan To Kagaku Ryoho. 2007 Feb; 34:(2):293-6.
http://www.pier-online.jp/0385-0684/contents_abstract.php?serial_no=34020&seq=39

HSL9012
Mori K.
[Introduction 'why is it multinational clinical trial now?']
Gan To Kagaku Ryoho. 2007 Feb; 34:(2):290-2
http://www.pier-online.jp/0385-0684/contents_abstract.php?serial_no=34020&seq=38

HSL9013
Fujiwara Y.
[Introduction: 'The scope of this forum' and 'the necessity of introduction of compassionate use system in Japan'].
Gan To Kagaku Ryoho 2007 Feb; 34:(2):281-3
http://www.pier-online.jp/0385-0684/contents_abstract.php?serial_no=34020&seq=35

HSL9025
Lee N, Broderick AJ, Chamberlain L.
What is 'neuromarketing'? A discussion and agenda for future research.
Int J Psychophysiol. 2007 Feb; 63:(2):199-204
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T3M-4K5JVM3-1&_user=10&_coverDate=02%2F28%2F2007&_rdoc=1&_fmt=full&_orig=search&_cdi=4950&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=21ae2817b71153ae848a75410f28d920

HSL9036
Mahoney ME.
Reflecting on the San Antonio Breast Cancer Symposium Past and Present
Breast Cancer Action Newsletter 2007 Feb-Mar
http://www.bcaction.org/Pages/SearchablePages/2007Newsletters/Newsletter095C.html

HSL9106
Triggle DJ.
Treating desires not diseases: a pill for every ill and an ill for every pill?
Drug Discov Today 2007 Feb; 12:(3-4):161-6
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T64-4MMP63V-1&_user=10&_coverDate=02%2F28%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=a958dd5b386664b5dbca5bab215ceda0

HSL9107
Bornfeld M.
Industry support questioned.
J Am Dent Assoc 2007 Feb; 138:(2):150
http://jada.ada.org/cgi/content/full/138/2/150

HSL9173
Shankar PR.
Educating health professionals about drug and device promotion: a Nepalese perspective.
PLoS Med 2007 Feb; 4:(2):e89
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040089

HSL9251
Madden EA.
The interaction between intellectual property and drug regulatory systems: global perspectives.
IDrugs 2007 Feb; 10:(2):116-20
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17285464&query_hl=6&itool=pubmed_DocSum

HSL9254
Honey K.
Drug designed to raise HDL levels falls down.
J Clin Invest 2007 Feb; 117:(2):282
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17273546

HSL9255
Clary C, Loebel A, Lombardo I, Alphs L, Binneman B, Vanderburg D, Warrington L, Parsons B, Fogel I, Herman B, Roberts H, Templeton H, Hughes D, Chappell P, Feltner D, Tobias K, Watsky E, Ramey T, Rappard F.
Comments on 'Presidential address: advocacy as leadership'.
Am J Psychiatry 2007 Feb; 164:(2):346
http://ajp.psychiatryonline.org/cgi/content/full/164/2/346?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=Clary+C&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT

HSL9256
Sharfstein SS.
Dr. Sharfstein Replies
Am J Psychiatry 2007 Feb; 164:(2):346-a
http://ajp.psychiatryonline.org/cgi/content/full/164/2/346-a?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=sharfstein&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT

HSL9260
Binymin KA, Phillips K.
'To do no harm'.
Rheumatology (Oxford) 2007 Feb; 46:(2):368-70
http://rheumatology.oxfordjournals.org/cgi/content/full/46/2/368

HSL9277
Shah S, van Geijn H.
Managing the risks of off-licence prescribing in pregnancy.
Eur J Obstet Gynecol Reprod Biol 2007 Feb; 130:(2):156-9
http://linkinghub.elsevier.com/retrieve/pii/S0301-2115(06)00505-7

HSL9364
Johnston SC, Hauser SL.
Marketing and drug costs: who is laughing and crying?
Ann Neurol 2007 Feb; 61:(2):11A-12A
http://www3.interscience.wiley.com/cgi-bin/abstract/114125634/ABSTRACT?CRETRY=1&SRETRY=0

HSL9810
Rivkees SA.
Should off-label drug use be off-the-table?
J Pediatr Endocrinol Metab 2007 Feb; 20:(2):171-2
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17396432&query_hl=8&itool=pubmed_DocSum

HSL9814
Barlow K.
Salesperson, doctor, or leader: choose your rep wisely.
Health Care Strateg Manage 2007 Feb; 25:(2):11
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17373471&query_hl=14&itool=pubmed_DocSum

HSL9816
Cross M.
How much trouble does health care marketing cause?
Manag Care 2007 Feb; 16:(2):39-40,
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17361509&query_hl=16&itool=pubmed_DocSum

HSL9820
Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A.
Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
J Clin Pharm Ther 2007 Feb; 32:(1):101-7
http://www.blackwell-synergy.com/doi/full/10.1111/j.1365-2710.2007.00794.x?cookieSet=1

HSL9821
Reiter KL, Kilpatrick KE, Greene SB, Lohr KN, Leatherman S.
How to develop a business case for quality.
Int J Qual Health Care 2007 Feb; 19:(1):50-5
http://intqhc.oxfordjournals.org/cgi/content/full/19/1/50

HSL10002
Kozma CM.
Educating patients on hype versus science.
Manag Care Interface 2007 Feb; 20:(2):41-2
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17405581&query_hl=7&itool=pubmed_DocSum

HSL10062
Kartal M.
Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products.
Phytother Res 2007 Feb; 21:(2):113-9
http://www3.interscience.wiley.com/cgi-bin/abstract/113471664/ABSTRACT

HSL10327
Dooley AG.
Off-label drug use.
Med Health R I 2007 Feb; 90:(2):63-5
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17500258

HSL10332
Monedero P.
[Medical ethics and the pharmaceutical industry].
Rev Esp Anestesiol Reanim 2007 Feb; 54:(2):69-72
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17390687

HSL11005
Moncrieff J.
In Debate: Are Antidepressants as Effective as Claimed? No, They Are Not Effective at All
Can J Psychiatry 2007 Feb; 52:(2):96–97
http://publications.cpa-apc.org/media.php?mid=328

HSL11148
Damanhori AH, Al Khaja KA, Sequeira RP, Al-Ansari TM.
Diurnal variation of prescribing pattern of primary care doctors in Bahrain.
J Eval Clin Pract 2007 Feb; 13:(1):25-30
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2753.2006.00642.x

HSL11736
Das SC, Mandal M, Mandal SC.
A Critical Study on Availability and Price Variation Between Different Brands -- Impact on Access of Medicines
Indian J Pharm Sci 2007 Jan-Feb; 69:(1):160-163
http://www.ijpsonline.com/text.asp?2007/69/1/160/32139

HSL11901
Feinstein SH.
Review of Medicines out of control? Antidepressants and the conspiracy of goodwill.
Psychiat Serv 2007 Feb; 58:(2):275-276

HSL11947
Chaves GC, Oliveira MA, Hasenclever L, de Melo LM.
[Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
Cad Saude Publica 2007 Feb; 23:(2):257-67
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0102-311X2007000200002&lng=en&nrm=iso&tlng=en

HSL13651
Healy D.
One flew over the conflict of interest nest
World Psychiatry 2007 Feb; 6:(1):26–27
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17342217

HSL8085
Harris G.
F.D.A. Widens Safety Reviews on New Drugs
New York Times 2007 Jan 31
http://www.nytimes.com/2007/01/31/washington/31fda.html?ei=5059&en=e6adede7a14ab463&hp=&ex=1170306000&partner=AOL&pagewanted=print

HSL8086
Vedantam S.
FDA Revamps Process for Safety of Drugs After Approval
Washington Post 2007 Jan 31
http://www.washingtonpost.com/wp-dyn/content/article/2007/01/30/AR2007013001496_pf.html

HSL8194
Kirkey S.
Panel urges widescale HPV vaccination
CanWest News Service 2007 Jan 31
http://www.canada.com/topics/bodyandhealth/story.html?id=cbce3557-9323-4046-a86f-6ef357ee402d

HSL8202
Gorman B.
Merck's Special Interest
The Motley Fool 2007 Jan 31
http://www.fool.com/investing/dividends-income/2007/01/31/mercks-special-interest.aspx?source=eptyholnk303100&logvisit=y&npu=y&bounce=y

HSL8204
Salant JD.
Pfizer, Halliburton Grab Democrats as Hearings Loom
Bloomberg.com 2007 Jan 31
http://www.bloomberg.com/apps/news?pid=20601070&sid=a8fyOQYvbFQ8&refer=politics

HSL8249
Nainggolan L.
Cardiovascular Agents Top Adult and Elderly Drug Charts
Medscape 2007 Jan 31
http://www.medscape.com/viewarticle/551539

HSL8074
Medawar C.
'What they’ve done is just despicable …'
Social Audit 2007 Jan 30
http://www.socialaudit.org.uk/6070130-REVIEW.htm#"What%20they’ve%20done

HSL8103
Bridges A.
FDA Proposes Report Cards on New Drugs
The Associated Press 2007 Jan 30
http://www.pennlive.com/newsflash/health/index.ssf?/base/politics-3/1170188962137470.xml&storylist=health

HSL8205
Associated Press.
Merck lobbies states to require cervical-cancer vaccine for schoolgirls
BostonHerald.com 2007 Jan 30
http://news.bostonherald.com/national/view.bg?articleid=180060&format=text

HSL8300
Childs D.
Could Drug Ads Be Bad for Your Health?
ABC News (US) 2007 Jan 30
http://abcnews.go.com/Health/story?id=2833516&page=1

HSL8498
Heavey S.
TV Drug Ads Play on Emotions, U.S. Study Says
Reuters 2007 Jan 30
http://www.medscape.com/viewarticle/551501

Page 70 of 144 pages ‹ First  < 68 69 70 71 72 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909